NCT01855542

Brief Summary

Chloride-rich isotonic crystalloid solutions have been shown to exert electrolyte imbalance and metabolic acidosis in critically ill patients. The aim of this investigation is to compare the influence of 0.9% saline and plasmalyte solution on acid-base balance and electrolytes in healthy patients undergoing major spine surgeries.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2012

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2012

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2013

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 7, 2013

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 16, 2013

Completed
Last Updated

May 16, 2013

Status Verified

May 1, 2013

Enrollment Period

10 months

First QC Date

May 7, 2013

Last Update Submit

May 13, 2013

Conditions

Keywords

metabolic acidosis, plasmalyte solution, 0.9% normal saline

Outcome Measures

Primary Outcomes (1)

  • base-excess

    Change from baseline in base-excess at postoperative 12 h

Study Arms (2)

0.9% saline

EXPERIMENTAL

In each group, patients received either 0.9% normal saline or plasmalyte solution until end of surgery.

Other: 0.9% normal saline

plasmalyte

ACTIVE COMPARATOR

In each group, patients received either 0.9% normal saline or plasmalyte solution until end of surgery.

Other: plasmalyte

Interventions

In each group, patients received either 0.9% normal saline or plasmalyte solution until end of surgery.

0.9% saline

In each group, patients received either 0.9% normal saline or plasmalyte solution until end of surgery.

plasmalyte

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients (aged 20-65) undergoing cervical or lumbar spine surgery who were diagnosed spinal stenosis involving more than tow spinal levels.

You may not qualify if:

  • ASA class III or IV
  • pregnancy
  • breast feeding
  • lack of mental weakness(including disabled)
  • using diuretics
  • respiratory insufficiency
  • metabolic acidosis or alkalosis
  • coagulation disorder
  • over hydtration
  • renal failure or serum creatinine \> 1.4mg/dl
  • anemia (Hemoglobin 9.0\<mg/dl)
  • hypernatremia (Na \> 145mEq/L)
  • Hyperkalemia (K\>5.5mEq/L)
  • psychological medication or any drugs that influences renal clearance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine

Seoul, Seoul, 120-752, South Korea

Location

Related Publications (1)

  • Song JW, Shim JK, Kim NY, Jang J, Kwak YL. The effect of 0.9% saline versus plasmalyte on coagulation in patients undergoing lumbar spinal surgery; a randomized controlled trial. Int J Surg. 2015 Aug;20:128-34. doi: 10.1016/j.ijsu.2015.06.065. Epub 2015 Jun 27.

MeSH Terms

Conditions

Acidosis

Interventions

Saline SolutionPlasmalyte A

Condition Hierarchy (Ancestors)

Acid-Base ImbalanceMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 7, 2013

First Posted

May 16, 2013

Study Start

March 1, 2012

Primary Completion

January 1, 2013

Study Completion

January 1, 2013

Last Updated

May 16, 2013

Record last verified: 2013-05

Locations